Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

INSULIN DELIVERY SYSTEMS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Delivery Systems in US$ Million by the following major Insulin Delivery Mechanisms - Insulin Syringes, Insulin Pumps (External), and Insulin Pens. The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players such as Animas Corporation, Antares Pharma, Inc., Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Disetronic Medical Systems, Inc., Generex Biotechnology Corp., Insulet Corp, Medical Plastic Devices Inc., Medtronic Inc., Novo Nordisk A/S, Patton Medical Devices, LP, Sanofi-Aventis, Smiths Medical MD, Inc., and Ypsomed AG. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Code : MCP-6283
Price : $3950
Companies : 73
Pages : 441
Date : April 2010
Market Data Tables : 98

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  INSULIN DELIVERY SYSTEMS (Complete Report) Pages : 441   | $3950
 
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS3$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
II. EXECUTIVE SUMMARY51$2250
  1. INDUSTRY OVERVIEW.....II-19 $700  
   Increasing Diabetes Prevalence – A Major Growth Propeller.....II-1
Diabetes – Taking Toll in Developing Countries.....II-1
1$100
   Insulin Therapy for Diabetes Management.....II-2
Insulin Delivery Systems – A Quick Market Primer.....II-2
1$100
   Insulin Pump Therapy: Convenient Alternate to Insulin Injection.....II-3
United States – The Largest Global Market for Insulin Pumps (External).....II-3
Rosy Future Ahead for Insulin Pens.....II-3
1$100
   Select Brands of Disposable Insulin Pens by Manufacturer.....II-4
Select Brands of Reusable Insulin Pens by Manufacturer.....II-4
Innovations in Insulin Delivery – An Overview.....II-4
1$100
   Select Next-Generation Insulin Delivery Techniques and Devices.....II-5
Pulmonary Insulin Delivery via Inhalers.....II-5
Early Jitters Make Pharma Majors Abandon Inhaled Insulin Research.....II-5
1$100
   Pulmonary Insulin Delivery Research Still Remains Unabated.....II-6
Transdermal Delivery of Insulin via Patches.....II-6
1$100
   Transmucosal Insulin Delivery via Mouth Spray.....II-7
Nasal Delivery of Insulin via Nasal Mucosa.....II-7
Hydrogels for Insulin Delivery.....II-7
1$100
   Oral Insulin Delivery.....II-8
Artificial Pancreas Technology – A Promising Approach for Diabetes Treatment.....II-8
1$100
   Competitive Landscape.....II-9
Insulin Syringes.....II-9
Insulin Pumps.....II-9
Insulin Pens.....II-9
1$100
  2. MAJOR TRENDS & ISSUES.....II-104 $400  
   Pre-Filled Syringes: Gaining Diabetics Attention.....II-10
Insulin Pumps Market: Tough Ground for New Entrants.....II-10
Innovative Features Spruce Up the Market for Insulin Pumps.....II-10
2$200
   Combination Products: The Latest Trend in the Insulin Pump Market.....II-12
Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market.....II-12
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-12
1$100
   Insulin Pump Market Issues.....II-13
Insulin Pump Training Not Receiving Adequate Attention.....II-13
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-13
1$100
  3. DIABETES & INSULIN DELIVERY SYSTEMS - AN ABSTRACT.....II-1410 $700  
   Diabetes - A Fatal Disease.....II-14
Risk Factors for Diabetes.....II-14
Types of Diabetes.....II-14
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM).....II-14
1$100
   Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM).....II-15
Long Term Complications of Diabetes.....II-15
1$100
   Pancreas: The Main Source of Insulin in Human Body.....II-16
Types of Insulin & Administration.....II-16
1$100
   Oral Administration.....II-17
Goal of Insulin Therapy.....II-17
Insulin Delivery Systems – An Overview.....II-17
1$100
   Insulin Syringes.....II-18
Insulin Needles.....II-18
Insulin Pens.....II-18
1$100
   Advantages of Insulin Pens.....II-19
Disadvantages of Insulin Pens.....II-19
External Insulin Pumps.....II-19
Insulin Pump Components.....II-19
1$100
   How Does an Insulin Pump Work?.....II-20
Insulin Pump Delivery Rates.....II-20
1$100
   Advantages of Insulin Pumps.....II-21
More Accurate and Consistent.....II-21
Adjusting Time Zones While Traveling.....II-21
Enhances Blood Sugar Control in Pediatric Patients.....II-21
Improves Quality of Life.....II-21
Disadvantages of Insulin Pumps.....II-21
High Cost.....II-21
High Involvement.....II-21
1$100
   Diabetic Ketoacidosis Risk.....II-22
Glucose Testing at Regular Intervals.....II-22
Regular Rotation of Infusion Set.....II-22
Carrying Back-up Kit.....II-22
Regular Refilling of Pump.....II-22
Insulin Jet Injectors.....II-22
1$100
   Pen Injectors.....II-23
1$100
  4. RESEARCH & DEVELOPMENT.....II-243 $300  
   Nanotechnology Victoria, Monash University Develop SAW Generated Mechanism, for Insulin
  Delivery.....II-24
Medtronic Emphasizes Cutting-Edge Features of a Closed-Loop Diabetes Management System,
  Currently Under Development.....II-24
Toray Industries and Hoshi University Discover a New Approach for Insulin Delivery Via
  Nasal Spray.....II-24
1$100
   A New Study Demonstrates Superior Benefits of Novo Nordisk's Next Generation.....II-25
Phosphagenics to Commence Phase II Clinical Trials of Transdermal Insulin Delivery
  System.....II-25
Oramed Pharmaceuticals Begins Phase Ia Trials of Insulin Suppository.....II-25
Debiotech and STMicroelectronics Unveil First Prototype of a Disposable Insulin
  Nanopump.....II-25
1$100
   Braunschweig University Scholar Devises Wristwatch Insulin Pump.....II-26
1$100
  5. PRODUCT INTRODUCTIONS.....II-273 $300  
   Novo Nordisk Introduces Preloaded Pen.....II-27
BD Medical Unveils BD AutoShield Pen Needle.....II-27
Novo Nordisk Introduces Flexpen.....II-27
Polymedicure Unveils Insulin syringes.....II-27
Johnson & Johnson Medical India to Unveil Insulin Pumps.....II-27
Generex Rolls Out Oral Insulin Spray.....II-27
1$100
   Eli Lilly Launches KwikPen.....II-28
Smith Medical Launches Cozmo in China.....II-28
Medtronic Unveils Arabic Language Insulin Pump.....II-28
1$100
   Medtronic Launches New Diabetes Monitoring System.....II-29
Eli Lilly to Unveil New Insulin Pen, Memoir.....II-29
1$100
  6. RECENT INDUSTRY ACTIVITY.....II-308 $600  
   JDRF Enters into Partnership with Animas.....II-30
Medtronic Acquires Certain Assets from PreciSense.....II-30
MannKind Inks Agreement to Acquire Pfizer’s German Insulin Facility.....II-30
Owen Mumford Inks Deal with Sanofi-Aventis.....II-30
1$100
   Medingo Obtains FDA Approval for Marketing Insulin Micropump.....II-31
Insulet Wins CE Mark Approval for OmniPod® Insulin Management System.....II-31
Sanofi-aventis Receives FDA Approval for Apidra® SoloSTAR®.....II-31
Novo Nordisk Receives FDA Approval for NovoLog® Labeling Change.....II-31
1$100
   Patton Medical Devices, Unomedical Enter into Partnership Agreement.....II-32
Sanofi-aventis Wins Canadian and EU Approval for ClikSTAR® Insulin Pen.....II-32
DexCom and Animas Amend Insulin Pump Joint Development Deal.....II-32
Medingo Secures FDA Approval for Solo MicroPump Insulin Delivery System.....II-32
1$100
   Qualitest Pharmaceuticals Recalls Accusure Insulin Syringes.....II-33
Novartis Completes Acquisition of Nektar’s Pulmonary Business.....II-33
Smiths Medical Acquires Zhejiang Zheda Medical Instrument.....II-33
ICBS Acquires Vectoris Pharma.....II-33
1$100
   Sagent Pharma Acquires Rights to ChaSyr, a Multi-Chamber Syringe.....II-34
Novo Nordisk Hands Over Inhaled Insulin Patents to Aradigm.....II-34
Eli Lilly and Alkermes Terminate Inhaled Insulin Development Deal.....II-34
Novo-Nordisk Drops Development Plan of Inhaled Insulin.....II-34
Generex, Dongsung Pharm Enter Agreement for Generex Oral-lyn.....II-34
1$100
   Novo Nordisk Gains FDA Clearance for NovoLog®.....II-35
Novo Nordisk to Construct Insulin Plant in China.....II-35
Generex Biotechnology Enters into Distribution Agreement with SciGen.....II-35
Rexam and Eli Lilly to Expand Manufacturing Base for Insulin Pens.....II-35
Merrion to Develop and Market Novo Nordisk’s Insulin Analogues.....II-35
1$100
   Smiths Medical to Cease Insulin Pumps Sale, Exist Diabetes Business.....II-36
Covidien Recalls Mislabelled Syringes.....II-36
Animas Recalls Insulin Pumps with Faulty Battery Cap.....II-36
NationsHealth Acquires Diabetes Care & Education.....II-36
1$100
   Insulet Inks Agreement with DexCom.....II-37
Insulet Partners with Flextronics.....II-37
Debiotech Allies with STMicroelectronics.....II-37
SpectRx Divests Insulin Pump Business.....II-37
1$100
  7. FOCUS ON SELECT GLOBAL PLAYERS.....II-387 $500  
   Animas Corporation (USA).....II-38
Antares Pharma, Inc. (USA).....II-38
1$100
   Becton, Dickinson and Company (USA).....II-39
Eli Lilly and Company (USA).....II-39
1$100
   F. Hoffmann-La Roche, Ltd. (Switzerland).....II-40
Disetronic Medical Systems, Inc. (USA).....II-40
1$100
   Generex Biotechnology Corp. (Canada).....II-41
Insulet Corp. (USA).....II-41
1$100
   Medical Plastic Devices Inc. (Canada).....II-42
Medtronic Inc. (USA).....II-42
1$100
   Novo Nordisk A/S (Denmark).....II-43
Patton Medical Devices, LP (USA).....II-43
Sanofi-Aventis (France).....II-43
1$100
   Smiths Medical MD, Inc. (USA).....II-44
Ypsomed AG (Switzerland).....II-44
1$100
  8. GLOBAL MARKET PERSPECTIVE.....II-45   
   Insulin Syringes:.....II-45
Table 1: World Recent Past, Current & Future Analysis for Insulin Syringes Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-45
1$300
   Table 2: World Historic Review for Insulin Syringes Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-461$300
   Table 3: World 13-year Perspective for Insulin Syringes Market by Geographic Region – Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....II-471$300
   Insulin Pumps (External):.....II-48
Table 4: World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-48
1$300
   Table 5: World Historic Review for Insulin Pumps (External) Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-491$300
   Table 6: World 13-year Perspective for Insulin Pumps (External) Market by Geographic Region – Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....II-501$300
   Insulin Pens:.....II-51
Table 7: US and Europe Recent Past, Current & Future Analysis for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-51

Table 8: US and Europe Historic Review for Insulin Pens Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-51
1$300
III. MARKET29$1950
  1. THE UNITED STATES.....III-116 $1075  
   A. Market Analysis.....III-1
Diabetes – A Cause of Concern.....III-1
Table 9: Diabetes Prevalence by Diabetes Type in Millions in the US (2008) (includes corresponding Graph/Chart).....III-1
Surging Diabetic Population Keeps Demand Ticking for Insulin Delivery
  Systems.....III-1
1$150
   External Insulin Pumps: A Key Mechanism for Insulin Delivery.....III-2
Insulin Pens Gaining Immense Prominence.....III-2
Jet Injectors: The Costliest Insulin Delivery System.....III-2
1$75
   Competitive Analysis by Insulin Delivery System.....III-3
Becton Dickinson – The Insulin Syringes Market Leader.....III-3
Table 10: US Insulin Syringes Market (2007): Percentage Share Breakdown by Leading Companies - Becton Dickinson, Kendall, and Others (includes corresponding Graph/Chart).....III-3
Medtronic – The Insulin Pumps Major.....III-3
Table 11: US Insulin Pumps Market (2008): Percentage Share Breakdown of Leading insulin Pump Manufacturers – Medtronic, Animas and Others Comparison of Major Insulin Pump Systems Based on Select Parameters (includes corresponding Graph/Chart).....III-3
1$150
   Product Introductions.....III-41$75
   Strategic Corporate Developments.....III-55$375
   Major Players.....III-105$375
   B. Market Analytics.....III-15
Table 12: US Recent Past, Current & Future Analysis for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-15

Table 13: US Historic Review for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-15
1$150
   Table 14: US 13-year Perspective for Insulin Delivery Systems – Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-16
1$150
  2. EUROPE.....III-177 $525  
   A. Market Analysis.....III-17
European Preference for Insulin Pens Overshadows the Rest of the World
  Demand.....III-17
Insulin Pump Therapy Gaining Favor Among Europeans.....III-17
1$75
   Strategic Corporate Developments.....III-181$75
   Major Players.....III-192$150
   B. Market Analytics.....III-21
Table 15: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-21
1$150
   Table 16: Europe Historic Review for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-221$150
   Table 17: Europe 13-year Perspective for Insulin Delivery Systems – Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-23
1$150
  3. REST OF WORLD.....III-246 $450  
   A. Market Analysis.....III-24
Product Introductions.....III-24
2$150
   Strategic Corporate Developments.....III-261$75
   Major Players.....III-271$75
   B. Market Analytics.....III-28
Table 18: Rest of World Recent Past, Current & Future Analysis for Insulin Delivery Systems – Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-28
1$150
   Table 19: Rest of World Historic Review for Insulin Delivery Systems – Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-29

Table 20: Rest of World 13-year Perspective for Insulin Delivery Systems – Percentage Breakdown of Value Sales for Insulin Syringes and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015.....III-29
1$150
IV. COMPETITIVE LANDSCAPE 351$995
  
Total Companies Profiled: 72 (including Divisions/Subsidiaries - 82)

Region/Country                 Players


The United States                 34 
Canada                             2
Japan                              2
Europe                            10 
     France                        1
     Germany                       1
     The United Kingdom            2
     Rest of Europe                6
Asia-Pacific (Excluding Japan)    31 
Middle-East                        3
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign